MedTrace Logo

Third Ventricle Echographic Study for Neuro-intensive Care Unit Patients

NCT02830269 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 100

Last updated 2018-12-05

No results posted yet for this study

Summary

Transcranial Doppler ultrasonography is usually used in the evaluation and management of patients with brain injury. This noninvasive method measures local blood flow velocity and direction in the proximal portions of large intracranial arteries. The operator requires a short training and experience to perform. The third ventricle diameter measurement by transcranial duplex flow sonography was performed in healthy volunteers . This studies show similar results in those obtained with the MRI or Computer Tomography (CT). Currently the third ventricle diameter measurements by transcranial Doppler ultrasonography was not validated for neuro-intensive care unit patients. The investigators propose to used recent ultrasound system to validate the third ventricle diameter measurements in comparison with the standard method (CT).

Conditions

  • Neuro-intensive Care Unit Patients
  • Brain Injuries

Interventions

DEVICE

Transcranial Doppler ultrasonography measurements

Third ventricle diameter measurements with standard method (CT) and Transcranial Doppler ultrasonography

Sponsors & Collaborators

  • University Hospital, Montpellier

    lead OTHER

Principal Investigators

  • GERALD CHANQUES, MD, Ph D · University Hospital, Montpellier

  • Pierre-François PERRIGAULT, MD · University Hospital, Montpellier

  • Paul BORY, MD · University Hospital, Montpellier

Eligibility

Min Age
18 Years
Max Age
100 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-08-18
Primary Completion
2017-05-16
Completion
2017-05-16

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02830269 on ClinicalTrials.gov